Using ONCOhabitats to plan brain tumor surgery
Part of Cancer clinical trials.
This study tests a computer tool called ONCOhabitats that helps doctors plan surgery and treatment for a type of aggressive brain tumor called glioblastoma. By using your MRI scans, the tool may help guide the surgeon to remove as much tumor as possible while sparing healthy brain tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a high-grade glioma (a type of fast-growing brain tumor) seen on MRI
- You are scheduled to have surgery to remove the tumor
- You have had a complete MRI scan before surgery, including specific types of images
- You are willing to sign a consent form to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced imaging to help surgeons remove as much of a malignant brain tumor as safely possible. It may be a good fit if you have a new diagnosis of glioblastoma or a certain astrocytoma and are healthy enough for surgery.
This trial tests whether artificial intelligence can help plan radiation therapy better for people with a type of brain cancer called glioblastoma. It may lead to more precise treatment and fewer side effects.
This trial is testing a new way to find and remove glioblastoma brain tumors using a special MRI scan. It may help doctors remove more of the tumor safely during surgery.
This study tests a new way to plan and deliver radiation therapy for glioblastoma (an aggressive brain tumor) using special MRI scans to target cancer cells more precisely. The goal is to improve treatment effectiveness while reducing harm to healthy brain tissue.
This study tests a new way to grow miniature versions of your brain tumor in the lab (called organoids) from a small piece of your tumor removed during surgery. The results may help doctors understand which treatments might work best for you in the future.
This study uses special MRI imaging with deuterium to see how radiotherapy affects newly diagnosed glioblastoma (GBM) with an IDH-wildtype tumor. It may help doctors better understand treatment response and timing, potentially improving how radiotherapy is planned.
Hear when a new Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.